Why and how to reduce variations in medical practice?

Paths for improving care quality

Paris, September 5th, 2018

Pourquoi et comment réduire les variations de pratiques médicales ?

Des pistes pour améliorer la pertinence des soins

Paris, 5 septembre 2018
Séminaire en anglais


SPEAKERS

Gwyn Bevan

Professor of Policy Analysis
Department of Management, London School of Economics & Political Science
Houghton Street
London WC2A 2AE
England

www.lse.ac.uk/management/people/academic-staff/gbevan

Biography

Professor Gwyn Bevan is Professor of Policy Analysis at the London School of Economics & Political Science, where he has previously been the Head of the Department of Management. He was also a Director at the Commission for Health Improvement, which regulated quality of care in the NHS in England and Wales from 2000 to 2004. He is a member of the Advisory Committee on Resource Allocation that advises the Secretary of State for Health on the formulas to be used in allocating resources for health care and public health in England, and the Advisory Board to Her Majesty's Inspector of Constabulary on the programme of regular force inspections. He is a Visiting Professor at the Blavatnik School of Government of the University of Oxford and Affiliate Professor, Istituto di Management of the Scuola Superiore Sant'Anna, Pisa.


David Goodman

MD MS, Professor of Pediatrics and Co-Founder of the Wennberg International Collaboration
The Dartmouth Institute for Health Policy and Clinical Practice
Hanover, NH
USA 03755
tdi.dartmouth.edu/about/our-people/directory/david-goodman-md-ms

Biography

David C. Goodman is Professor of Pediatrics and of Health Policy at The Dartmouth Institute for Health Policy and Clinical Practice; and Co-Principal Investigator, Dartmouth Atlas of Health Care. He is also an Adjunct Professor at the Institute for Social and Preventive Medicine at the Univ. of Bern. For the past thirty years, Goodman's has studied the causes and consequences of health care variation. His current research is directed towards unwarranted variation in the use of neonatal intensive care services.
Dr. Goodman is a founding investigator of the Dartmouth Atlas of Health Care and has led multiple Atlas projects on such topics as the physician workforce, end-of-life cancer care, post hospital discharge care, and care for infants and children. His has published in the New England Journal of Medicine, JAMA, Health Affairs, Pediatrics, and The New York Times. He has also served on the editorial boards of the journals Health Services Research, Pediatrics, and The Journal of Pediatrics.
Dr. Goodman has been a member of numerous national and international advisory committees and was the recent Chair of the U.S. Council on Graduate Medical Education. With his colleague, Prof. Gwyn Bevan of the London School of Economics, in 2010 he co-founded the Wennberg International Collaborative.


Sabina Nuti

Full Professor
Sant'Anna School of Advanced Studies
Pisa
Italy
www.santannapisa.it/it/sabina-nuti

Biography

Sabina Nuti is full professor of Health Management at Sant'Anna School of Advanced Studies of Pisa, a public university that holds a unique position within the Italian higher education system. She is member of the Expert Panel on Effective Ways of Investing in Health of the European Commission for the triennium 2016-2019.
Prof. Nuti is in charge of the performance evaluation system for the healthcare sector in Tuscany Region and for a network of other twelve Italian Regions. She is a Member of the Scientific Committee of the National Outcome Program at National Agency for Regional Health Services. She has been a visiting professor at the University of Toronto. She is responsible for European and National research projects regarding healthcare management, performance evaluation and policies, and author of various national and international publications. She has recently been appointed as a member of the Editorial Board of Health, Economics, Policy and Law, of the Cambridge University Press.


Zeynep Or

HDR, Research Director
IRDES, Institute for Research and Information in Health Economics
117bis rue Manin
75019 Paris
France

www.irdes.fr/recherche/equipe/or-zeynep.html

Biography

Zeynep Or is an economist and research director at the Institute for Research and Information in Health Economics (IRDES, Institut de recherche et documentation en économie de la santé). She has a PhD and the tenure in Economic Analysis from Sorbonne Paris-I University.
She specialises in evaluation of health system performance from an international comparative perspective, including the determinants of health outcomes, analysis of efficiency, equity and health care quality. She has published extensively on the measurement and determinants of variations in health care provision and utilisation, efficiency and quality of hospital services within and across countries, and the interaction between institutional and policy settings and health system performance.
Zeynep has been at IRDES since 2005 and has worked previously as a health economist and consultant for the Organisation for Economic Cooperation and Development (OECD) and the French National Institute of Medical Research (Inserm). She is an active member of several international networks such as European Observatory of Health Systems and Policy Monitor, European Health Policy Group, Wennberg International Collaboration. Since 2013, she is an associate editor of the journal Health Policy.


Lise Rochaix

Scientific director of the hospinnomics chair
Hospinnomics

Hôtel-Dieu
1 Parvis de Notre-Dame
75004 Paris

France

www.hospinnomics.eu/en/members/hospinnomics-team/

Biography

Lise Rochaix, Ph.D., is full professor in the economics department of the University of Paris 1 Panthéon-Sorbonne since September 2014 and holds the Paris School of Economics chair in health economics, Hospinnomics endowed by the Hospitals of Paris (AP-HP). She has a Master of Sciences and a PhD in economics (1991) from the Department of Economics and Related Studies, at York university (UK). She started her carrier as a researcher in the French National Institute for Scientific Research (CNRS) and subsequently became lecturer in economics at Dauphine university. She became full professor through the French national competition in 1994 and was first appointed at the University of Western Brittany and then at Aix-Marseille University. She has taken part in various governmental reports and was seconded to the forecasting division of the French Treasury (90-93). In 2006, she was appointed by the President of the Senate to join the Board of the French National Health Board (Haute Autorité de Santé - HAS) where she set up HAS’s economic remit and a new dedicated committee: the economics and public health evaluation committee (CEESP - Commission d’Evaluation Economique et de Santé Publique), in charge of the evaluation of health care strategies and new technologies, which she chaired until the end of her mandate in January 2014. In October 2015, she has been appointed chair of the board of directors of the technical agency in charge of hospital information ATIH (Agence Technique d’Information Hospitalière). She has been elected chair of the European Health Economics Association (EuHEA), starting July 2018. Her research interests focus on the evaluation of public policies, in an international comparative perspective. She has published widely on topics related to regulatory issues in the healthcare sector, with both equity and efficiency considerations.


Diane Watson

Chief Executive
Bureau of Health Information (BHI) Suite 1101 Level 11
67 Albert Avenue
Chatswood NSW 2067
www.bhi.nsw.gov.au/About_us/our_people

Biography

Dr Diane Watson is the Chief Executive of the Bureau of Health Information. She has led the establishment of three reporting agencies in Australia that use big data to drive decisions on healthcare provision nationally and locally.
Prior to joining BHI, Dr Watson was the inaugural Chief Executive Officer of the Victorian Agency for Health Information, established in 2016 to monitor and report on public and private services that stimulate quality and safety improvements, increase transparency and accountability, and inform the community. She was also the inaugural Chief Executive of the National Health Performance Authority, established by the Australian Government to monitor, and report on, the performance of 1000+ public and private hospitals and 300+ health regions.
Dr Watson was the inaugural Chief Executive of the Bureau of Health Information from 2009 to 2012. She has held senior management positions for almost 20 years measuring, monitoring and reporting on the performance of healthcare systems to drive improvements in health, care and productivity. During this time, she has set the future direction of high profile, board governed agencies and inspired a strong sense of purpose among a highly talented and specialised workforce.


ORGANISATION